BIOMAT Database Logo BIOMAT Database Logo

Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India. 2010

Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Tuberculosis Research Centre (ICMR), Chennai, India.

OBJECTIVE Resistance to nevirapine (NVP) has been described with single dose preventive regimens in other populations. Our aim was to study the pattern and prevalence of HIV drug resistance (DR) at baseline (during pregnancy) and after delivery among antenatal women exposed to single dose NVP for prevention of parent to child transmission (PPTCT). METHODS HIV-infected, ART-naive primigravidae between 18-25 years of age, attending government antenatal clinics in Chennai, Vellore or Madurai were recruited. Drug resistance testing was carried out during pregnancy and after Sd-NVP treatment (one month after delivery) by Viroseq sequencing. HIV-1 testing by DNA PCR was done in newborns at 30 days. RESULTS Thirty one women were enrolled but only twenty six plasma specimens were analyzable (24 paired and two postnatal only). No major mutations were observed in any drug class at baseline though many polymorphisms were observed in both the reverse transcriptase and protease genes. Mutations to non-nucleoside reverse transcriptase inhibitors (NNRTI) were observed post-delivery in 33 per cent of women who were treated with Sd-NVP. None of the infants were HIV-positive. CONCLUSIONS Among pregnant ART-naive women, baseline HIV drug resistance was not observed. A high rate of development of NNRTI class resistance among women treated with single-dose NVP was observed. Our results emphasize the need to implement more effective PPTCT regimens, minimizing emergence of drug resistance and thereby preserving long-term treatment options for HIV-infected women in India.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
May 2007, AIDS research and human retroviruses,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
January 2011, Indian journal of pathology & microbiology,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis.
January 2011, PloS one,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
July 2005, The Journal of infectious diseases,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
January 2011, Antiviral therapy,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.
December 2008, Journal of acquired immune deficiency syndromes (1999),
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
January 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.
May 2006, Proceedings of the National Academy of Sciences of the United States of America,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women.
October 2009, AIDS research and human retroviruses,
Lakshmi Rajesh, and K Ramesh, and Luke Elizabeth Hanna, and P R Narayanan, and Soumya Swaminathan
Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine.
November 2007, Lancet (London, England),
Copied contents to your clipboard!